FDA
-
-
-
-
-
-
-
Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
-
-
-
-
-
-
-
Bluejay Diagnostics raises $4.5 million in private placement
-
-
-
-
-
-
-
Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting
-
-
-
-
-
-
-
SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients
-
-
-
-
-
-
-
Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)
-
-
-
-
-
-
-
bluejay Diagnostics (BJDX) Announces 1:20 Reverse Stock Split
-
-
-
-
-
-
-
Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

